A. Nakamura et al., Activation of beta(2)-adrenoceptor prevents Shiga toxin 2-induced TNF-alpha gene transcription, J AM S NEPH, 12(11), 2001, pp. 2288-2299
Exposure of renal tubular epithelial cells to shiga toxin 2 (Stx-2) causes
cytotoxicity, and the potency of this toxin is enhanced in the presence of
tumor necrosis factor-alpha (TNF-alpha). It has been shown that Stx-2 induc
es TNF-alpha production and that activation of beta (2)-adrenoceptors downr
egulates TNF-alpha. However, little is known about the signaling pathway by
which beta (2)-adrenoceptor agonists suppress the Stx-2-induced TNF-alpha
gene transcription. The possible signaling components involved in this path
way were investigated. Human adenocarcinoma-derived renal tubular epithelia
l cells (ACHN) were exposed to Stx-2 in the presence or absence of a beta (
2)-adrenoceptor agonist. Mitogen-activated protein kinase (MAPK), activatin
g protein-1 (AP-1), and nuclear factor-kappaB (NF-kappaB) were measured to
evaluate the regulatory mechanisms involved in TNF-alpha gene transcription
. Stx-2 (4 pg/ml) stimulated MAPK (p42/p44, p38) and AP-1 and increased TNF
-alpha promoter activity by 2.4-fold. The increase in TNF-alpha was attenua
ted by both a p42/p44 inhibitor, PD098059 (10(-6) M), and a p38 inhibitor,
SB203580 (10(-6) M), and AP-1-binding activity was inhibited by PD098059. T
erbutaline ( 10(-6) M to 10(-8) M) suppressed MAPK (p42/p44, p38), NF-kappa
B (p50. p65), and TNF-alpha promoter activity in a dose-dependent way that
was prevented by the beta (2)-adrenoceptor antagonist, ICI118.551. However,
inhibition of MAPK (p42/p44) and TNF-alpha promoter activity was partially
prevented by the cAMP-protein kinase (PKA) inhibitors, H-89 (5 x 10(-6) M)
and KT5720 (10(-5) M), whereas the suppression of p38 MAPK or NF-kappaB (p
50) was not blocked by these inhibitors. The suppression of NF-kappaB (p65)
was completely overcome by H-89 or KT5720. In summary, the downregulation
of TNF-alpha transcription by terbutaline was mediated by in inhibitory eff
ect of beta (2)-adrenoceptor activation on MAPK (p42/p44, p38) and NF-kappa
B (p50/p65), which were exerted through a cAMP-PKA pathway and a cAMP-indep
endent mechanism. It is likely that cAMP-PKA and MAPK (p42/p44, p38) may pl
ay a critical role in the regulation of the Stx-2-induced TNF-alpha transcr
iption via beta (2)-adrenoceptor activation.